Literature DB >> 19556940

Biennial [corrected] IV zoledronic acid (Reclast) for prevention of osteoporosis.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19556940

Source DB:  PubMed          Journal:  Med Lett Drugs Ther        ISSN： 0025-732X            Impact factor:   1.909


× No keyword cloud information.
  1 in total

Review 1.  Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass.

Authors:  Ronald C Hamdy
Journal:  Drug Des Devel Ther       Date:  2010-11-18       Impact factor: 4.162
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.